436 results on '"Miyajima, Akira"'
Search Results
2. Unique lipid composition maintained by extracellular blockade leads to prooncogenicity
3. MP18-14 A MULTI-INSTITUTIONAL PROSPECTIVE STUDY OF FOCAL THERAPY WITH HISTOTRIPSY USING HIGH-INTENSITY FOCUSED ULTRASOUND FOR PATIENTS WITH LOCALIZED PROSTATE CANCER IN JAPAN
4. Correction: Current status and future outlook of ultrasound treatment for prostate cancer
5. Transcatheter renal arterial embolization for intractable urinary fistula occurring after robot-assisted partial nephrectomy: a case report
6. Current status and future outlook of ultrasound treatment for prostate cancer
7. Laparoscopic Adrenalectomy
8. Impact of tumor contact surface area on collecting system entry in robot-assisted partial nephrectomy: a retrospective analysis
9. MP09-03 COMPARATIVE STUDY OF SIGNIFICANT CANCER DETECTION IN MAGNETIC RESONANCE IMAGING-TRANSRECTAL ULTRASOUND FUSION IMAGE-GUIDED PROSTATE TARGET BIOPSY AND TRANSPERINEAL TEMPLATE-GUIDED SYSTEMATIC BIOPSY: A 15-CENTER PROSPECTIVE STUDY IN JAPAN
10. MP09-08 PREDICTIVE VALUE OF LACDINAC-GLYCOSYLATED PROSTATE SPECIFIC ANTIGEN AT 3 MONTHS AFTER FOCAL THERAPY WITH HIGH-INTENSITY FOCUSED ULTRASOUND FOR DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER DURING FOLLOW-UP: A MULTI-INSTITUTIONAL STUDY
11. Supplementary Table 2 from The Prognostic Significance of Vasohibin-1 Expression in Patients with Upper Urinary Tract Urothelial Carcinoma
12. Supplementary Table 3 from The Prognostic Significance of Vasohibin-1 Expression in Patients with Upper Urinary Tract Urothelial Carcinoma
13. Supplementary Table 2 from The Prognostic Significance of Vasohibin-1 Expression in Patients with Upper Urinary Tract Urothelial Carcinoma
14. Supplementary Figure Legends 1-2, Table Legends 1-3 from The Prognostic Significance of Vasohibin-1 Expression in Patients with Upper Urinary Tract Urothelial Carcinoma
15. Supplementary Table 1 from The Prognostic Significance of Vasohibin-1 Expression in Patients with Upper Urinary Tract Urothelial Carcinoma
16. Supplementary Figure 1 from The Prognostic Significance of Vasohibin-1 Expression in Patients with Upper Urinary Tract Urothelial Carcinoma
17. Supplementary Figure 2 from The Prognostic Significance of Vasohibin-1 Expression in Patients with Upper Urinary Tract Urothelial Carcinoma
18. Supplementary Table 3 from The Prognostic Significance of Vasohibin-1 Expression in Patients with Upper Urinary Tract Urothelial Carcinoma
19. Supplementary Figure 1 from The Prognostic Significance of Vasohibin-1 Expression in Patients with Upper Urinary Tract Urothelial Carcinoma
20. Supplementary Figure 2 from The Prognostic Significance of Vasohibin-1 Expression in Patients with Upper Urinary Tract Urothelial Carcinoma
21. Supplementary Figure Legends 1-2, Table Legends 1-3 from The Prognostic Significance of Vasohibin-1 Expression in Patients with Upper Urinary Tract Urothelial Carcinoma
22. Supplementary Table 1 from The Prognostic Significance of Vasohibin-1 Expression in Patients with Upper Urinary Tract Urothelial Carcinoma
23. A case of post-BCG therapy renal granuloma concurrent with ureteral carcinoma
24. The Role of the Magnetic Resonance Imaging for the Accurate Management of Focal Therapy with High-Intensity Focused Ultrasound for the Localized Prostate Cancer
25. IDH2 stabilizes HIF‐1α‐induced metabolic reprogramming and promotes chemoresistance in urothelial cancer
26. Reply by Authors
27. Usefulness of LacdiNAc-glycosylated Prostate-specific Antigen Density for Predicting Pathological Findings of Magnetic Resonance Imaging-transrectal Ultrasound Fusion Image-guided Prostate Biopsy for the Patients With Highest Prostate Imaging Reporting and Data System Category ≥3
28. Risk Factors for Severe Erectile Dysfunction after Focal Therapy with High-Intensity Focused Ultrasound for Prostate Cancer
29. In which cases does collecting system entry occur in robot-assisted partial nephrectomy? Development of a novel predictive model based on the contact surface area of the tumor to the renal parenchyma
30. Correction: Komiyama et al. RNA-seq and Mitochondrial DNA Analysis of Adrenal Gland Metastatic Tissue in a Patient with Renal Cell Carcinoma. Biology 2022, 11, 589
31. PD13-05 CHANGES WITH TIME IN PROGNOSTIC FACTORS IN LOCALIZED PROSTATE CANCER SURVIVORS AFTER LOW-DOSE-RATE PERMANENT SEED IMPLANT BRACHYTHERAPY WITH IODINE-125; CONDITIONAL SURVIVAL ANALYSIS
32. PD40-04 HOW DOES MAGNETIC FIELD STRENGTH IN MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING AFFECT SIGNIFICANT PROSTATE CANCER DETECTION? : A MULTICENTER PROPENSITY SCORE–MATCHED ANALYSIS
33. PD40-06 USEFULNESS OF PROSTATE SPECIFIC ANTIGEN–GLYCOSYLATION ISOMER FOR SIGNIFICANT CANCER DETECTION AND PATHOLOGICAL FINDINGS OF INDEX PROSTATE CANCERS ON MAGNETIC RESONANCE IMAGING–TRANSRECTAL ULTRASOUND FUSION IMAGE-GUIDED BIOPSY: A PROSPECTIVE MULTICENTER STUDY
34. PD57-11 IMPACT OF CONTACT SURFACE AREA AND PI-RADS CATEGORY ON THE CAPSULAR INVASION OF LOCALIZED CANCER WITH SERUM PROSTATE-SPECIFIC ANTIGEN LEVELS ≤20 NG/ML AND TUMOR-CAPSULE CONTACT
35. RNA-seq and Mitochondrial DNA Analysis of Adrenal Gland Metastatic Tissue in a Patient with Renal Cell Carcinoma
36. Preoperative factors affecting the operative outcomes of laparoscopic nephrectomy
37. Impact of stone volume on treatment outcomes of percutaneous nephrolithotripsy
38. Development and future prospective of treatment for localized prostate cancer with high-intensity focused ultrasound
39. Risk factors for recurrence after operation in patients with pT1a renal cell carcinoma: sub-analysis of the multi-institutional national database of the Japanese Urological Association
40. How long should urologists observe patients with prostate cancer after radical prostatectomy? Weibull analysis
41. Current Status of Endoscopic Surgery in Japan : The 15th National Survey of Endoscopic Surgery by the Japan Society for Endoscopic Surgery
42. V08-12 Y-SHAPED INCISIONS AND THREE-FLAP UMBILICOPLASTY: A NOVEL LAPAROENDOSCOPIC SINGLE-SITE SURGICAL APPROACH FOR PATIENTS WITH SYMPTOMATIC URACHAL SINUS
43. MP46-13 IMPACT OF INTRA-PROCEDURAL PROSTATE COMPRESSION AND ANDROGEN DEPRIVATION THERAPY IN WHOLE-GLAND THERAPY WITH HIGH-INTENSITY FOCUSED ULTRASOUND ON LOCALIZED PROSTATE CANCER: A RETROSPECTIVE CONSECUTIVE CASE-SERIES ANALYSIS FOR 12-YEAR FOLLOW-UP
44. MP36-08 PRE-PROCEDURAL LOW IIEF-5 AND TREATMENT OF PZ WITH ADJACENT NVB AND THE EJACULATORY DUCT WERE ASSOCIATED WITH SEXUAL DYSFUNCTION AFTER FOCAL THERAPY WITH HIGH-INTENSITY FOCUSED ULTRASOUND: A MULTI-INSTITUTIONAL PROSPECTIVE STUDY
45. PD13-01 NOVEL SIMULATING MODEL OF THE SURVEILLANCE DURATION AFTER LOW DOSE RATE BRACHYTHERAPY FOR PROSTATE CANCER PATIENTS: AN INDIVIDUALIZED RISK-BASED METHOD APPLYING WEIBULL DISTRIBUTIONS
46. MP64-10 HOW LONG SHOULD UROLOGISTS OBSERVE PATIENTS WITH PROSTATE CANCER AFTER RADICAL PROSTATECTOMY?: WEIBULL ANALYSIS
47. Effects of psoas major muscle volume in predicting the prognosis of patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy
48. Bacillus Calmette-Guérin Perfusion Treatment via Cutaneous Ureterostomy for Carcinoma in Situ of the Upper Urinary Tract
49. Effectiveness of Steroid Pulse Therapy for Systemic Side Effects after Bacillus Calmette-Guérin Intravesical Instillation Therapy: A Series of Five Cases
50. The Role of Hypertension and Renin-angiotensin-aldosterone System Inhibitors in Bleomycin-induced Lung Injury
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.